Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (11)
- Therapeutics (8)
- Medical Sciences (7)
- Medical Genetics (5)
- Medical Specialties (4)
-
- Life Sciences (3)
- Cancer Biology (2)
- Cell and Developmental Biology (2)
- Chemicals and Drugs (2)
- Male Urogenital Diseases (2)
- Obstetrics and Gynecology (2)
- Pharmacy and Pharmaceutical Sciences (2)
- Respiratory Tract Diseases (2)
- Virus Diseases (2)
- Biology (1)
- Cardiovascular Diseases (1)
- Diagnosis (1)
- Enzymes and Coenzymes (1)
- Hormones, Hormone Substitutes, and Hormone Antagonists (1)
- Immunology and Infectious Disease (1)
- Immunoprophylaxis and Therapy (1)
- Investigative Techniques (1)
- Medical Cell Biology (1)
- Medical Immunology (1)
- Medical Pathology (1)
- Nervous System Diseases (1)
- Oncology (1)
- Keyword
-
- Cancer (9)
- Breast cancer (4)
- Immunotherapy (3)
- Gene therapy (2)
- Prostate cancer (2)
-
- Treatment (2)
- ALK (1)
- ALK inhibitor (1)
- ALK+ (1)
- APACHE II (1)
- Adenocarcinoma of lung (1)
- Adenovirus (1)
- Adoptive cell transfer (1)
- Alectinib (1)
- Ambroxol (1)
- Anaplastic lymphoma kinase (1)
- Anaplastic thyroid cancer (1)
- Androgen (1)
- Animals (1)
- Anions (1)
- Anticancer agents (1)
- Aromatic-L-Amino-Acid Decarboxylases (1)
- B7-H1 antigen analysis and genetics (1)
- Berberine (1)
- Bronchoscopy (1)
- CXC (1)
- Cancer metabolism (1)
- Cancer patients (1)
- Cancer treatment (1)
- Carbon (1)
- Publication Year
- Publication
-
- The Science Journal of the Lander College of Arts and Sciences (14)
- NYMC Faculty Publications (7)
- College of Osteopathic Medicine (TUN) Publications and Research (2)
- Faculty Publications & Research of the TUC College of Osteopathic Medicine (2)
- Faculty Publications & Research of the TUC College of Pharmacy (2)
- Publication Type
Articles 31 - 31 of 31
Full-Text Articles in Neoplasms
Pregnancy Associated Breast Cancer: An Analysis Of Fetal Treatment Risk, Melissa Barnett
Pregnancy Associated Breast Cancer: An Analysis Of Fetal Treatment Risk, Melissa Barnett
The Science Journal of the Lander College of Arts and Sciences
There are several viable treatment options for patients with PABC considered un-harmful to fetal development. Trastusumab, or Herceptin, targets HER2 protein and successfully combats aggressive breast cancer. In standard doses, it appears to be safe to the fetus even when administered during the first trimester. A likely side effect of Herceptin is anhydramnios, which can be monitored for throughout the stages of a pregnancy (Shrim et al. 2008). Anthracyclines, commonly used in chemotherapy, appear to be non-toxic, and have been used to successfully cure PABC patients in their second and third trimester. However, first trimester spontaneous abortions are documented to …